Remote ischaemic preconditioning does not alter perioperative cytokine production in high-risk cardiac surgery

Heart Asia

Volumn 4, Issue 1, 2014, Pages 97-101

  Williams, Jenni M ^a   Young, Paul ^b,c   Pilcher, Janine ^c   Weatherall, Mark ^b,c,d   Miller, John Holmes ^a   Beasley, Richard ^b,c   La Flamme, Anne Camille ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

^c MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^d UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AGED; AORTIC VALVE REPAIR; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; FEMALE; HEART EJECTION FRACTION; HEART SURGERY; HIGH RISK PATIENT; HUMAN; ISCHEMIC PRECONDITIONING; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPAIR; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REMOTE ISCHEMIC PRECONDITIONING; SURGICAL RISK;

EID: 84949115156     PISSN: None     EISSN: 17591104     Source Type: Journal    
DOI: 10.1136/heartasia-2012-010122     Document Type: Article

References (29)

1. Kharbanda RK, Mortensen UM, White PA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002;106:2881-3.
2. Gho BC, Schoemaker RG, van den Doel MA, et al. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 1996;94:2193-200.
3. Rahman IA, Mascaro JG, Steeds RP, et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation 2010;122:S53-9.
4. Karuppasamy P, Chaubey S, Dew T, et al. Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation? Basic Res Cardiol 2011;106:511-19.
5. Morita S. Remote ischemic preconditioning. Is it time to introduce it in clinical practice? Circ J 2011;75:1821-2.
6. Konstantinov IE, Arab S, Kharbanda RK, et al. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics 2004;19:143-50.
7. Kharbanda RK, Peters M, Walton B, et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 2001;103:1624-30.
8. Dawn B, Xuan YT, Guo Y, et al. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res 2004;64:61-71.
9. Wei M, Kuukasjarvi P, Laurikka J, et al. Cytokine responses and myocardial injury in coronary artery bypass grafting. Scand J Clin Lab Invest 2001;61:161-6.
10. Liu KD, Altmann C, Smits G, et al. Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit Care 2009;13:R104.
11. Takayama H, Soltow LO, Chandler WL, et al. Does the type of surgery effect systemic response following cardiopulmonary bypass? J Card Surg 2007;22:307-13.
12. Whitten CW, Hill GE, Ivy R, et al. Does the duration of cardiopulmonary bypass or aortic cross-clamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery? Anesth Analg 1998;86:28-33.
13. Young PJ, Dalley P, Garden A, et al. A pilot study investigating the effects of remote ischemic preconditioning in high risk cardiac surgery using a randomised controlled double-blind protocol. Basic Res Cardiol 2012;107:256-65.
14. Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13.
15. Swaanenburg JC, Loef BG, Volmer M, et al. Creatine kinase MB, troponin I, and troponin T release patterns after coronary artery bypass grafting with or without cardiopulmonary bypass and after aortic and mitral valve surgery. Clin Chem 2001;47:584-7.
16. Kawahito K, Adachi H, Ino T. Influence of surgical procedures on interleukin-6 and monocyte chemotactic and activating factor responses: CABG vs. valvular surgery. J Interferon Cytokine Res 2000;20:1-6.
17. Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res 2008;79:377-86.
18. Cheung MM, Kharbanda RK, Konstantinov IE, et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006;47:2277-82.
19. Zhou W, Zeng D, Chen R, et al. Limb ischemic preconditioning reduces heart and lung injury after an open heart operation in infants. Pediatr Cardiol 2010;31:22-9.
20. Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, et al. Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. J Am Coll Cardiol 2005;46:450-6.
21. Wang Y, Yin B, Liu S, et al. Cardioprotective effect by tumor necrosis factor-alpha and interleukin-6 through late preconditioning in unstable angina patients. Arch Med Res 2007;38:80-5.
22. Heusch G, Musiolik J, Kottenberg E, et al. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans. Circ Res 2011;110:111-15.
23. Wan S, DeSmet JM, Barvais L, et al. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;112:806-11.
24. Hong DM, Mint JJ, Kim JH, et al. The effect of remote ischaemic preconditioning on myocardial injury in patients undergoing off-pump coronary artery bypass graft surgery. Anaesth Intensive Care 2010;38:924-9.
25. Node K, Fujita M, Kitakaze M, et al. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 2003;108:839-43.
26. Rosenson RS, Tangney CC, Casey LC. Inhibition of proinflammatory cytokine production by pravastatin. Lancet 1999;353:983-4.
27. Belhomme D, Peynet J, Louzy M, et al. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999;100:II340-4.
28. Haroun-Bizri S, Khoury SS, Chehab IR, et al. Does isoflurane optimize myocardial protection during cardiopulmonary bypass? J Cardiothorac Vasc Anesth 2001;15:418-21.
29. Kawamura T, Kadosaki M, Nara N, et al. Effects of sevoflurane on cytokine balance in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2006;20:503-8.